Year
Edition number
№11 / 2021
Press Release
Translated to English
Sukhikh G.T., Dolgushina N.V., Shmakov R.G., Klimov V.A., Yarotskaya E.L., Petrova U.L.
Pregnancy outcomes after maternal COVID-19 vaccination during pregnancy: preliminary data5-8
Reviews
Shipitsyna E.V., Shirshova N.Yu., Kogan I.Yu.
Vaccination during pregnancy: present and future9-16
Kirakosyan E.V., Nazarenko T.A., Pavlovich S.V.
Search for the causes of reproductive system disorders: a research review18-25
Gaponenko A.A., Mityurina E.V., Frankevich V.E.
The follicular fluid metabolomic profile as a marker for oocyte quality in assisted reproductive technology programs26-31
Babayan A.A., Makarova N.P., Kondakova N.V., Gokhberg Ya.A., Nepsha O.S., Kalinina E.A.
Uterine fluid analysis as a new opportunity to increase implantation ratesin assisted reproductive technology programs32-40
Savostina G.V., Perminova S.G., Ekimov A.N., Veyukova M.A.
Preimplantation genetic testing for embryo aneuploidy: opportunities, problems, and prospects42-49
Bashmakova N.V., Polyakova I.G., Symaniuk E.E., Khramtsova A.Yu.
Consulting gamete and embryo donors and surrogate mothers: problems and their solution ways in world practice50-55
Gokhberg Ya.A., Timofeeva A.V., Kalinina E.A.
Molecular markers for endometrial receptivity in assisted reproductive technology programs56-62
Mikhailova N.D., Mishieva N.G., Kirillova A.O., Martazanova B.A., Dzhincharade L.G.
In vitro oocyte maturation64-70
Chernukha G.E., Tabeeva G.I., Rshtuni S.D., Mashaeva R.I., Chernykh V.B., Marchenko L.A.
Genes involved in premature ovarian failure71-80
Zyryanov S.K., Butranova O.I., Chenkurov M.S.
Chloramphenicol: new possibilities of the old drug81-94
Andreeva E.N., Absatarova Yu.S.
The place of alternative therapy in the algorithms for managing patients with climacteric syndrome in the context of personalized medicine96-102
Original Articles
Translated to English
Kulakova E.V., Nepsha O.S., Ekimov A.N., Drapkina Yu.S., Makarova N.P., Ibragimova L.K., Sysoeva A.P., Kalinina E.A.
Preimplantation genetic testing of embryos in assisted reproductive technology programs in patients with external genital endometriosis104-112
Translated to English
Ibragimova L.K., Smol'nikova V.Yu., El'darov Ch.M., Bobrov M.Yu., Agadzhanyan D.S., Romanov E.A., Kalinina E.A.
Metabolomic profile of follicular fluid and embryo culture media in patients with extragenital endometriosis114-124
Translated to English
Nepsha O.S., Kulakova E.V., Ekimov A.N., Drapkina Yu.S., Makarova N.P., Kraevaya E.E., Kalinina E.A.
Value of embryonic mitochondrial DNA in predicting the effectiveness of assisted reproductive technologies125-134
Translated to English
Mityurina E.V., Perminova S.G., Kravchenko A.V., Kozyrina N.V., Veyukova M.A., Gaponenko A.A.
Morphological abnormalities in oocytes in patients with HIV infection receiving antiretroviral therapy135-142
Translated to English
Shamina M.A., Timofeeva A.V., Fedorov I.S., Kalinina E.A.
Assessment of the expression level of hsa_pir_020497 piRNA in the follicular fluid of patients with different in vitro fertilization outcomes143-153
Translated to English
Makarova N.P., Lobanova N.N., Kulakova E.V., Nepsha O.S., Ekimov A.N., Kalinina E.A.
Impact of preimplantation genetic testing on assisted reproductive technology outcomes in couples with male factor infertility154-164
Translated to English
Drapkina Yu.S., Kulakova E.V., Nepsha O.S., Ekimov A.N., Makarova N.P., Kalinina Е.А.
Improvement of the embryological stage in assisted reproduction treatment with hyaluronan-enriched culture medium in couples using preimplantation genetic testing for aneuploidy166-174
Translated to English
Melkozerova O.A., Okulova E.O., Mikhelson A.A., Tretyakova T.B.
Molecular genetic predictors and ovarian reserve in women with deep infiltrating endometriosis175-186
Exchange of Experience
Translated to English
Dmitrieva I.E., Nazarenko T.A., Burduli A.G., Polushkina E.S., Khokhlova S.V.
Fertility outcomes in women after therapy for non-Hodgkin lymphoma187-193
Bespalova O.N., Zhernakova T.S.
Experience with Intralipid in early reproductive losses194-201
Uruimagova A.T., Prilepskaya V.N., Mezhevitinova E.A., Donnikov A.E., Abakarova P.R., Dovletkhanova E.R., Gusakov K.I., Odyvanova A.A.
Efficiency and acceptability of two-stage therapy for recurrent bacterial vaginosis202-212
Kvashnina E.V., Tutakov M.A., Vakhlova O.S., Tomina E.V., Shilova N.V.
Effect of hormone replacement therapy with estradiol in frozen embryo transfer on estrogen metabolism in women with various polymorphisms of catechol-O-methyltransferase gene213-220
Yureneva S.V., Prokofieva S.V., Spiridonova N.V., Yurasova E.A., Ilyina L.M.
Evaluation of patients’ satisfaction with Angeliq Micro in real clinical practice after 13 cycles of treatment in Russia222-228
Suturina L.V., Dikke G.B.
Experience in the use of low-dosed levonorgestrel-containing intrauterine system LCS16 and combined oral contraceptive containing 30 mcg ethinyl estradiol and 3 mg drospirenone in young women230-236
Guidelines for the Practitioner
Stuklov N.I., Basiladze I.G., Kisly N.D.
Iron deficiency in Russia: main problems and possible solutions237-244
Kalugina A.A., Boyarsky K.Yu., Makolkin A.A., Zvereva I.O., Voznesenskaya Yu.V., Kholodov D.V.
Review of the results of clinical studies of follitropin delta in ovarian stimulation protocols. The first experience of its use in Russia246-264
Kostava M.N.
HPV-associated diseases: questions and answers267-276
Clinical Notes
Pribushenya O.V., Lazarevich A.A.
Monochorionic-triplet pregnancy with twin reversed arterial perfusion syndrome278-285
